1-3 of 3
Kirsti Honnashagen
Close
Sort by
Journal Articles

Immune Monitoring of Vaccine Quality and Persistence of Specific T Cell Responses in Five AML Patients Receiving Extended Dendritic Cell Vaccination Under Compassionate Use

Iris Bigalke, MD, Judith Eckl, PhD, Guri Solum, MSc, Kirsti Hønnåshagen, Msc, Lisbeth Skoge, MSc, Yngvar Fløisand, MD PhD, Dag Josefsen, MD PhD, Stein Sæbøe-Larssen, PhD, Christiane Geiger, PhD, Dolores Schendel, PhD, Gunnar Kvalheim, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2718.
https://doi.org/10.1182/blood-2018-99-114557
Published: 2018
Journal Articles

AML Patients in Minimal Residual Disease Vaccinated with a Novel Generation of Fast Dendritic Cells Expressing WT-1 and PRAME Mount Specific Immune Responses That Relate to Clinical Outcome

Iris Bigalke, Yngvar Fløisand, MD PhD, Guri Solum, Kirsti Hønnåshagen, Marianne Lundby, Kristina Anderson, MD PhD, Stein Sæbøe-Larssen, PhD, Else-Marit Inderberg, PhD, Judith Eckl, PhD, Dolores J Schendel, PhD, Gunnar Kvalheim, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3798.
https://doi.org/10.1182/blood.V126.23.3798.3798
Published: 2015
Journal Articles

Vaccination with a New Generation of Fast Dendritic Cells Transfected with mRNA from hTERT, Survivin and Autologous Tumor Mount Strong Immune Responses and Prolong Survival

Iris Bigalke, MD, Kirsti Honnashagen, Marianne Lundby, Julitta Kasten, Else Marit Suso Inderberg, PhD, Lisbeth Skoge, Stein Saboe-Larssen, PhD, Dolores J Schendel, PhD, Gunnar Kvalheim, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2440.
https://doi.org/10.1182/blood.V124.21.2440.2440
Published: 2014